Skip to search formSkip to main contentSkip to account menu

Bradykinin Receptor Antagonists

Known as: Receptor Blockers, Bradykinin, Bradykinin Antagonists, Antagonists, Bradykinin Receptor 
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.
National Institutes of Health

Related topics

Related topics

19 relations

Narrower (14)

B 9430B 9858CP 0597FR 165649
Bradykinin Receptor Antagonists [MoA]In Bloodaspects of radiation effectschemical synthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The early treatment of bradykinin angioedema, a challenge for emergency medicine.
Nicolas Javaud, Frédéric Lapostolle, David Sapir, Marie Dubrel, Frédéric Adnet and Olivier Fain, SAMU-SMUR 93, Assistance… 
2006
2006
Cooperative Activation of TLR 2 and Bradykinin B 2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi 1
We have previously reported that exogenous bradykinin activates immature dendritic cells (DCs) via the bradykinin B2 receptor… 
1996
1996
Rationally designed non-peptides: Variously substituted piperazine libraries for the discovery of bradykinin antagonists and other G-protein-coupled receptor ligands
SummaryMolecular modeling studies of potent decapeptide bradykinin antagonists suggested the de novo design of peptide mimetics… 
Review
1995
Review
1995
Overview Pulmonary - Allergy, Dermatological, Gastrointestinal & Arthritis: Bradykinin receptor antagonists
Recent research on bradykinin (BK) antagonists has focused on attempts to increase their potency, specificity and stability… 
1993
1993
Design of potent, cyclic peptide bradykinin receptor antagonists from conformationally constrained linear peptides.
We are reporting eight new peptides, two of which represent the first examples of potent, cyclic peptide bradykinin receptor… 
1988
1988
Stimulation of bone resorption in cultured mouse calvaria by met-lys-bradykinin.
Met-lys-bradykinin, which may be released from kininogen due to cleavage by neutrophil leukocyte acid proteases, stimulated 45Ca… 
1986
1986
Human Ile-Ser-bradykinin, identical with rat T-kinin, is a major permeability factor in ovarian carcinoma ascites.
Ascites from patients with metastatic ovarian carcinoma contains high amounts of an activity that increases vascular permeability… 
1980
1980
Some properties of human pancreatic kallikrein and comparison with human trypsins and porcine kallikrein.
The properties of human pancreatic kallikrein purified from pancreatic juice were investigated. The enzyme is very stable at pH 8… 
1979
1979
Relationship between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of fitzgerald-trait plasma
Bovine high molecular weight kininogen (bHMWK) partially corrects the activated plasma thromboplastin time (aPTT) of Fitzgerald… 
1960
1960
Biological properties of synthetic bradykinin
Das synthetische Bradykinin H-L-Arg-L-Pro-L-Pro-Gly-L-Phe-L-Ser-L-Pro-L-Phe-L-Arg-OH hat (innerhalb der durch Unterschiede in der…